Abstract: A microcapsule capable of thoroughly encapsulating environmentally-sensitive or volatile core materials and capable of releasing said core material on contact with water. A process for manufacture of water soluble microcapsules comprising the admixture of a water soluble cellulosic material, a water soluble glucopyranosidyl material, at least two surfactants and core material, subjecting said mixture to an abrupt pressure change and drying the pressure-treated mixture.

Abstract: The invention is directed to a filamentous porous film that can act as a support for cellular attachment, growth and organization. The film is formed from filaments which define a matrix structure with pores.

Abstract: A composition comprising, in a physiologically acceptable medium, at least one sapogenin and a solubilizing system comprising: (a) at least one non-emulsifying ester of a fatty acid and/or of a fatty alcohol whose hydrocarbon-based chain contains at least 8 carbon atoms, or a plant oil, and (b) at least one branched fatty alcohol whose hydrocarbon-based chain contains at least 8 carbon atoms and/or at least one lipophilic UV screening agent. The solubilizing system according to the invention makes it possible to dissolve a sufficient amount of sapogenin, without recrystallization, for a period of time which is acceptable for cosmetic or dermatological use.

Abstract: The present invention relates to emulsions comprising an emulsification system comprising a mixture of at least one cationic surfactant, at least one anionic surfactant, at least one “bridging surfactant”, an oil and water, along with methods for preparing such emulsions. More specifically, the invention relates to stable, synergistic emulsions of various oils, water, cationic, anionic, and bridging surfactants that are useful in preparing a variety of finished personal care, laundry, and cleaning products, including for examples creams, lotions, sunscreens, liquid dish detergents, laundry detergents, automatic dishwasher detergents, hand soaps, laundry bars, personal cleansing bars, multi-purpose cleaners, multi-functional shampoos, body washes, and textile treatment compositions. The emulsifications of the present invention also may be employed in agricultural and pesticide applications. Additionally, the surfactant blends may be utilized in antimicrobial formulations (e.g.

Abstract: A stable, aqueous hair dyeing emulsion with good Theological properties is prepared, while simultaneously substantially reducing the manufacturing time and energy consumption, comprising at least one oxidation hair dyestuff precursor, by mixing a water-in-oil emulsion, comprising 10% to 50% by weight of at least one nonionic emulsifier, 10% to 50% by weight of at least one nonionic co-emulsifier selected from the group of C10-C22-fatty alcohols, C12-C18-fatty acid mono- and dialkanolamides and/or C10-C22-fatty acid esters with polyvalent alcohols, 5% to 40% by weight of oleic acid, and up to 25%, in particular 20% by weight of water, each calculated to the total w/o-emulsion composition, with an aqueous phase comprising at least one water-soluble surfactant. Mixing is carried out under shear force at 15° to 30° C., preferably at room temperature at about 20° to 25°.

Abstract: Disclosed herein are topical compositions and methods for using the same to relieve pain in humans, such as pain associated with cancer, bone injuries, old age, and many other forms of pain. Specifically, the present compositions comprise an effective amount of acetone, a salicylate-based compound and an emollient. In addition, the present compositions further comprise one or more compounds including, but not limited to, terpenes and essential oils. The present compositions may be in the form of a liquid (preferably a slightly viscous liquid) or other forms including, but not limited to, salves, creams, gels, ointments or sprays.

Abstract: A composition for improving memory and concentration in mammals with disorders associated with memory impairment. The composition comprises a combination of at least one phytoestrogen and at least one acetylcholinesterase inhibitor such as Huperzine A, or any derivative, analog, metabolite or combination thereof. The composition may further include at least one mammalian estrogen. The method of the invention comprises the co-administration of at least one phytoestrogen and at least one acetylcholinesterase inhibitor in a therapeutically effective amount. Additionally, a mammalian estrogen may be co-administered.

Abstract: A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 550 and 7500 ng base/mL.

Abstract: Disclosed are methods and compositions capable of rapidly preparing mammalian tissue and organs for harvesting and subsequent transplantation while minimizing the potential for infection of the harvested tissues and organs. This invention is also directed to methods and compositions used to prepare the donor for subsequent handling by a mortician.

Abstract: The present invention relates to a method for sequestering bile acids in a patient and to particular polymers for use in the method. The invention further relates to a method for reducing blood cholesterol, treating atherosclerosis, treating hypercholesterolemia and/or reducing plasma lipid content of a mammal. The methods of the invention comprise orally administering to the patient a therapeutically effective amount of a polymer characterized by a polyether backbone and amino or ammonium groups pendant therefrom. The amino nitrogen atoms can be substituted by one or more substituents independently selected from among substituted and unsubstituted, normal, branched and cyclic alkyl groups, and aryl groups. When the polymer comprises pendant ammonium or quaternary ammonium groups, the polymer will be associated with a pharmaceutically acceptable anion.

Abstract: Combinations of sunscreens comprising at least one specific anti uv-B filter with triazinoaniline structure and at least one specific anti UV-A filter selected from filters with benzoxazol substituted triazinoaniline structure and a long chain alkyl ester of a benzoxazolyl-aminophenyl-cyanoacrylic acid. Cosmetic and dermatological compositions containing them, optionally in combination with vitamins and/or other anti UV-A and anti UV-B filters.

Abstract: The invention concerns a cosmetic composition comprising a specific functionalized organopolysiloxane which is linear or cyclic. Said functionalized organopolysiloxane is used as emollient and/or carrier and/or anti-transfer agent in cosmetic compositions.

Abstract: Oral composition comprising a co-ground of at least two ingredients which are co-ground without the use of solvents and wherein the co-ground comprises each of at least two ingredients at a level of at least 5% by weight of the total weight of the co-ground, characterised in that the composition is an aqueous composition.

Abstract: A treatment patch includes a patch body having a contacting surface for placing on a skin surface of a treating tissues of a user, and a dressing layer which is provided on the contacting surface containing positively charged metallic ions for depolarizing negative ions accumulated under the skin surface of the treating tissues, wherein a far infrared ray emitter disposed on the. patch body for emitting far infrared rays penetrating into the treating tissues through the skin surface so as to provide an ion passway between the skin surface in contact with the dressing layer of the patch body and the treating tissues so as to enhance the depolarization of the positively charged ions of the dressing layer with the negative ions around the treating tissues of the user to relieve pain.

Abstract: A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 550 and 7500 ng base/mL.

Abstract: A method for reducing or preventing body malodour by topically applying to human skin a perfume component capable of selectively increasing the population of naturally occurring deodorising micro-organisms on the surface of the skin. The perfume component is preferably capable of inhibiting lysozyme.

Abstract: The present invention provides a method of avoiding rapid development of extreme hyperammonemia and metabolic acidosis in undiagnosed metabolically abnormal infants having an inherited metabolic disorder.

Abstract: A cosmetic composition is provided which includes menthol suspended in a carrier system of a crosslinked non-emulsifying siloxane elastomer and a volatile siloxane. The carrier system prevents crystallization and granulation of menthol from the cosmetic compositions.

Abstract: The invention relates to sun-protection formulations in solid or liquid form, containing organic and/or inorganic sunscreen filters having a prophylactic action against herpetic diseases of the skin, and to the use of said sun-screen formulations.

Abstract: The present invention relates to cosmetic compositions, particularly foaming cleansing compositions, comprising a cationic component and an anionic alkyl glucoester surfactant. These compositions are particularly useful as color-depositing shampoos containing cationic dyes.